Drug to treat canine lymphoma gets FDA approvalJanuary 3, 2017VetDC, Inc., a veterinary cancer therapeutics company, today announced that the U.S. Food and Drug Administration’s Center for Veterinary Medicine has granted a conditional approval of Tanovea™-CA1 (rabacfosadine for injection) for the treatment of lymphoma in dogs.
Education Center - SponsoredWhat's new for in-clinic hematology?by • ZoetisAdvancements in diagnostics provide greater opportunities to predict, prevent, diagnose and treat animal illnesses, more quickly, accurately and reliably. In hematology, new AI-powered technologies can help to elevate patient care and streamline workflows – driving meaningful change in the veterinary practice.
